CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,669,217 | +226.3% | 2,140,861 | +97.7% | 0.01% | +200.0% |
| Q2 2023 | $19,514,117 | -34.0% | 1,082,914 | -41.2% | 0.00% | +100.0% |
| Q1 2023 | $29,581,180 | -14.2% | 1,841,916 | -2.2% | 0.00% | -66.7% |
| Q4 2022 | $34,461,066 | -34.6% | 1,883,118 | -29.8% | 0.00% | -40.0% |
| Q3 2022 | $52,667,000 | -5.5% | 2,681,603 | -10.2% | 0.01% | -16.7% |
| Q2 2022 | $55,707,000 | -24.0% | 2,987,020 | -10.5% | 0.01% | 0.0% |
| Q1 2022 | $73,256,000 | -30.7% | 3,337,395 | -10.3% | 0.01% | -25.0% |
| Q4 2021 | $105,751,000 | +13.5% | 3,722,295 | -15.9% | 0.01% | +14.3% |
| Q3 2021 | $93,177,000 | -3.4% | 4,426,434 | -13.5% | 0.01% | -12.5% |
| Q2 2021 | $96,492,000 | +27.9% | 5,118,948 | +3.7% | 0.01% | +33.3% |
| Q1 2021 | $75,457,000 | +8.3% | 4,938,316 | -0.0% | 0.01% | 0.0% |
| Q4 2020 | $69,680,000 | -9.8% | 4,938,349 | +0.1% | 0.01% | -25.0% |
| Q3 2020 | $77,293,000 | -10.5% | 4,932,516 | +0.1% | 0.01% | -11.1% |
| Q2 2020 | $86,318,000 | +70.8% | 4,926,835 | +43.3% | 0.01% | +28.6% |
| Q1 2020 | $50,543,000 | -44.6% | 3,438,300 | -5.4% | 0.01% | -30.0% |
| Q4 2019 | $91,160,000 | +67.2% | 3,633,331 | +0.2% | 0.01% | +42.9% |
| Q3 2019 | $54,535,000 | -39.8% | 3,626,011 | +0.1% | 0.01% | -36.4% |
| Q2 2019 | $90,518,000 | +10.0% | 3,620,701 | +0.2% | 0.01% | +10.0% |
| Q1 2019 | $82,262,000 | -6.7% | 3,614,288 | +23.0% | 0.01% | -16.7% |
| Q4 2018 | $88,126,000 | +13.2% | 2,938,539 | +8.1% | 0.01% | +33.3% |
| Q3 2018 | $77,866,000 | – | 2,717,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 410,360 | $11,658,000 | 6.24% |
| 5AM Venture Management, LLC | 862,286 | $24,498,000 | 4.60% |
| Bain Capital Life Sciences Investors, LLC | 2,029,701 | $57,664,000 | 4.57% |
| Opaleye Management Inc. | 724,400 | $20,580,000 | 4.36% |
| Deep Track Capital, LP | 1,900,000 | $53,979,000 | 3.81% |
| BVF INC/IL | 3,003,879 | $85,340,000 | 3.10% |
| FRAZIER MANAGEMENT LLC | 1,384,293 | $39,328,000 | 3.03% |
| Altium Capital Management LP | 331,000 | $9,404,000 | 2.59% |
| Perceptive Advisors | 10,327,034 | $293,392,000 | 2.26% |
| MPM BioImpact LLC | 379,792 | $10,790,000 | 1.97% |